Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients-Reference-Cited by-同舟云学术

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

Published:2011-04-24 Issue:7 Volume:25 Page:929-939
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Cahn Pedro,Fourie Jan,Grinsztejn Beatriz,Hodder Sally,Molina Jean-Michel,Ruxrungtham Kiat,Workman Cassy,Van De Casteele Tom,De Doncker Piet,Lathouwers Erkki,Tomaka Frank

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference18 articles.

1. Efficacy and safety of once-daily regimens in the treatment of HIV infection;Molina;Drugs,2008

2. Better adherence with once-daily antiretroviral regimens: a meta-analysis;Parienti;Clin Infect Dis,2009

4. Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis;Mills;AIDS,2009

5. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial;Madruga;Lancet,2007

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure;Drug Design, Development and Therapy;2024-04

2. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes;Open Forum Infectious Diseases;2023-10-31

3. The Effectiveness of Different Doses or Types of Vitamin D Supplementation in HIV-Positive Individuals in Lahore;Pakistan Journal of Health Sciences;2023-04-30

4. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

5. Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D ² EFT;HIV Research & Clinical Practice;2022-08-08